merged_eu-covid-vaccines.txt
<question_number>1</question_number>
<answer>The court ruling against the European Commission could negatively impact Ursula von der Leyen's chances of securing a second term, as it casts a shadow on her leadership and the transparency of the EU's pandemic response under her direction.</answer>

<question_number>2</question_number>
<answer>The article suggests that the lack of transparency around the EU's vaccine purchasing strategy, which came under von der Leyen's leadership, has contributed to a sense of distrust among European voters about how officials have spent taxpayer money, which has in turn benefited far-right politicians.</answer>

<question_number>3</question_number>
<answer>The article indicates that von der Leyen will need to rely on a broad coalition, including center-left lawmakers like the Greens who have been critical of how she handled the coronavirus crisis, in order to secure the votes needed for her reconfirmation.</answer>

<question_number>4</question_number>
<answer>The article implies that the lack of transparency around the EU's vaccine procurement strategy under von der Leyen's leadership has contributed to a sense of distrust among European voters, which has benefited the rise of far-right politicians in the European Parliament.</answer>

<question_number>5</question_number>
<answer>The article does not directly connect the court's ruling on vaccine contracts to the rise of far-right politicians in the European Parliament. It only states that the lack of transparency around the vaccine contracts has contributed to a sense of distrust among European voters, which has in turn benefited far-right politicians.</answer>

<question_number>6</question_number>
<answer>The article suggests the timing of the court's ruling, coming just ahead of the vote on von der Leyen's future, could influence the upcoming vote, as it casts a shadow on her leadership.</answer>

<question_number>7</question_number>
<answer>The article states that the EU's initial vaccine campaign was marred by a slow start compared to Britain and the US, with the bloc taking a more conservative, budget-conscious approach, but later caught up and even surpassed other major countries after von der Leyen secured a contract with Pfizer-BioNTech.</answer>

<question_number>8</question_number>
<answer>The European Commission's statement that it had provided the European Parliament "full information" on the vaccine contracts contradicts the court's ruling that the Commission wrongly withheld information from the public.</answer>

<question_number>9</question_number>
<answer>The article states that The New York Times is involved in a separate pending case against the European Commission seeking access to text messages between von der Leyen and the Pfizer CEO, which is related to the court's ruling on the lack of transparency around the vaccine contracts.</answer>

<question_number>10</question_number>
<answer>The article suggests the court's ruling, which found the European Commission wrongly withheld information about the vaccine contracts, could further undermine public perception of the EU's pandemic response, especially given the recent rise of far-right politicians in the European Parliament.</answer>